Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America

Congenital toxoplasmosis remains a public health problem throughout the world. Long-term longitudinal studies are still needed to argument controversial screening and treatment strategies and to enable to accurately counsel parents. We conducted a prospective cohort study over 16 years in Marseilles...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26791
Acceso en línea:
http://dx.doi.org/10.1097/inf.0b013e3182129e70
https://repository.urosario.edu.co/handle/10336/26791
Palabra clave:
Congenital toxoplasmosis
Prevention of Retinochoroiditis in Congenital Toxoplasmosis
Europe
South America
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_0a2545e4b41acf48ab3019960511dbba
oai_identifier_str oai:repository.urosario.edu.co:10336/26791
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 14ac8f34-bbe7-4d61-9562-ef8f781391c251701355600fd7b7eac-8666-4d86-8a16-d53affe247a58185629e-f0c8-4412-80e4-2aea46c87592e2986de3-7ebf-477e-a44d-ce192c6554a3def1a92e-4546-4e33-b982-4b0aed9c742e03b8c52d-1599-41ad-9106-a559058a88312020-08-19T14:40:15Z2020-08-19T14:40:15Z2011-07-01Congenital toxoplasmosis remains a public health problem throughout the world. Long-term longitudinal studies are still needed to argument controversial screening and treatment strategies and to enable to accurately counsel parents. We conducted a prospective cohort study over 16 years in Marseilles, France. Seronegative pregnant women underwent monthly serological testing. Children were treated antenatally with rovamycine as soon as maternal infection was detected and with pyrimethamine and sulfadoxine in case of positive Toxoplasma PCR on amniotic fluid. Postnatal treatment with pyrimethamine and sulfadoxine was systematically prescribed for one year and possibly continued at the physician discretion. 127 children were included. 24 children (18.9%) presented ocular lesions causing visual impairment in eight cases. Eleven children (8.7%) presented with ocular lesions at birth, mostly macular. Sixteen children (12.6%) developed ocular lesions during follow-up, mostly peripheral. The first ocular lesion could occur as late as 12 years after birth. No significant risk factor of chorioretinitis was identified including gestational age at infection, type of antenatal treatment and shorter postnatal treatment. These results confirm the overall good prognosis of congenital toxoplasmosis in Europe but highlight though a low risk of late ocular manifestation. Chorioretinitis affected 18.9% of children suffering from congenital toxoplasmosis despite antenatal and neonatal screening associated with early treatment. Long-standing follow-up is needed because first lesion can occur as late as 12 years after birth. Late lesions were less often macular but nevertheless caused sometimes visual impairment.application/pdfhttp://dx.doi.org/10.1097/inf.0b013e3182129e70ISSN: 0891-3668EISSN: 1532-0987https://repository.urosario.edu.co/handle/10336/26791engWolters Kluwer603No. 7601The Pediatric Infectious Disease JournalVol. 30The Pediatric Infectious Disease Journal, ISSN: 0891-3668;EISSN: 1532-0987, Vol.30, No.7 (July, 2011); pp. 601-603https://journals.lww.com/pidj/Citation/2011/07000/Prevention_of_Retinochoroiditis_in_Congenital.15.aspxRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecThe Pediatric Infectious Disease Journalinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCongenital toxoplasmosisPrevention of Retinochoroiditis in Congenital ToxoplasmosisEuropeSouth AmericaPrevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South AmericaPrevención de la retinocoroiditis en la toxoplasmosis congénita Europa frente a América del SurarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Sauer, Arnaudde-la-Torre, AlejandraGomez-Marin, JorgeBourcier, TristanGarweg, JustusSpeeg-Schatz, ClaudeCandolfi, Ermanno10336/26791oai:repository.urosario.edu.co:10336/267912021-08-26 05:57:32.798https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
dc.title.TranslatedTitle.spa.fl_str_mv Prevención de la retinocoroiditis en la toxoplasmosis congénita Europa frente a América del Sur
title Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
spellingShingle Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
Congenital toxoplasmosis
Prevention of Retinochoroiditis in Congenital Toxoplasmosis
Europe
South America
title_short Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
title_full Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
title_fullStr Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
title_full_unstemmed Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
title_sort Prevention of Retinochoroiditis in Congenital Toxoplasmosis Europe Versus South America
dc.subject.keyword.spa.fl_str_mv Congenital toxoplasmosis
Prevention of Retinochoroiditis in Congenital Toxoplasmosis
Europe
South America
topic Congenital toxoplasmosis
Prevention of Retinochoroiditis in Congenital Toxoplasmosis
Europe
South America
description Congenital toxoplasmosis remains a public health problem throughout the world. Long-term longitudinal studies are still needed to argument controversial screening and treatment strategies and to enable to accurately counsel parents. We conducted a prospective cohort study over 16 years in Marseilles, France. Seronegative pregnant women underwent monthly serological testing. Children were treated antenatally with rovamycine as soon as maternal infection was detected and with pyrimethamine and sulfadoxine in case of positive Toxoplasma PCR on amniotic fluid. Postnatal treatment with pyrimethamine and sulfadoxine was systematically prescribed for one year and possibly continued at the physician discretion. 127 children were included. 24 children (18.9%) presented ocular lesions causing visual impairment in eight cases. Eleven children (8.7%) presented with ocular lesions at birth, mostly macular. Sixteen children (12.6%) developed ocular lesions during follow-up, mostly peripheral. The first ocular lesion could occur as late as 12 years after birth. No significant risk factor of chorioretinitis was identified including gestational age at infection, type of antenatal treatment and shorter postnatal treatment. These results confirm the overall good prognosis of congenital toxoplasmosis in Europe but highlight though a low risk of late ocular manifestation. Chorioretinitis affected 18.9% of children suffering from congenital toxoplasmosis despite antenatal and neonatal screening associated with early treatment. Long-standing follow-up is needed because first lesion can occur as late as 12 years after birth. Late lesions were less often macular but nevertheless caused sometimes visual impairment.
publishDate 2011
dc.date.created.spa.fl_str_mv 2011-07-01
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:40:15Z
dc.date.available.none.fl_str_mv 2020-08-19T14:40:15Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv http://dx.doi.org/10.1097/inf.0b013e3182129e70
dc.identifier.issn.none.fl_str_mv ISSN: 0891-3668
EISSN: 1532-0987
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26791
url http://dx.doi.org/10.1097/inf.0b013e3182129e70
https://repository.urosario.edu.co/handle/10336/26791
identifier_str_mv ISSN: 0891-3668
EISSN: 1532-0987
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 603
dc.relation.citationIssue.none.fl_str_mv No. 7
dc.relation.citationStartPage.none.fl_str_mv 601
dc.relation.citationTitle.none.fl_str_mv The Pediatric Infectious Disease Journal
dc.relation.citationVolume.none.fl_str_mv Vol. 30
dc.relation.ispartof.spa.fl_str_mv The Pediatric Infectious Disease Journal, ISSN: 0891-3668;EISSN: 1532-0987, Vol.30, No.7 (July, 2011); pp. 601-603
dc.relation.uri.spa.fl_str_mv https://journals.lww.com/pidj/Citation/2011/07000/Prevention_of_Retinochoroiditis_in_Congenital.15.aspx
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Wolters Kluwer
dc.source.spa.fl_str_mv The Pediatric Infectious Disease Journal
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167639216357376